Authors:
Kiran Pulidindi, Kunal Ahuja
Download free PDF
Plant Protein Hydrolysate Market Size & Share 2026-2035
Report ID: GMI7510
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Plant Protein Hydrolysate Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Plant Protein Hydrolysate Market Size
The plant protein hydrolysate market was valued at USD 2.41 billion in 2025, is projected to reach USD 2.55 billion in 2026, and is expected to expand at a 5% CAGR (2026-2035), reaching USD 3.93 billion by 2035.
Plant Protein Hydrolysate Market Key Takeaways
Market Leader: ADM led with over 14.1% market share in 2025.
Leading Players: Top 5 players in this market include ADM, Kerry Group, Roquette, DuPont/IFF, Cargill, which collectively held a market share of 26.9% in 2025.
The plant protein hydrolysate market is evolving from a specialized functional-ingredient category toward a more differentiated formulation input across performance nutrition, clinical nutrition, and value-added food systems. Demand is supported where rapid dispersibility, digestibility, and tailored peptide profiles solve a formulation constraint that intact plant proteins cannot address as effectively; adoption remains selective where price and sensory performance dominate purchasing decisions.
GMI Analyst View
Based on our proprietary demand-side estimation model, the plant protein hydrolysate market recorded revenues of USD 2.30 billion in 2024, reflecting consistent year-on-year growth driven by rising functional ingredient adoption in sports, clinical, and food and beverage manufacturing channels. Our demand tracking indicates that this growth momentum has been broad-based across application categories, with no single end-use segment distorting the aggregate trajectory heading into the 2025 base year.
Plant Protein Hydrolysate Market Trends, Growth Drivers & GMI Forecast Outlook
The market's forward trajectory depends on whether processors can translate functional performance into repeatable, commercially viable formulations. Sports nutrition and specialized food systems provide the clearest demand base, while expanded plant-protein processing capacity and more precise enzyme selection improve the economics and consistency required for broader adoption.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Sports and performance nutrition creates demand for hydrolysates because ingredient buyers are evaluating more than protein content: dispersibility, digestion positioning, sensory management, and compatibility with ready-to-drink or powder formats all influence formulation decisions. This favors suppliers able to provide consistent peptide profiles and technical support rather than simply low-cost protein inputs.
Pea-protein processing investment has particular strategic relevance because it can improve feedstock reliability for a source increasingly favored in allergen-conscious and plant-forward formulations. As the processing base matures, hydrolysate producers can pursue longer-term supply commitments with branded customers and reduce the volatility that has historically complicated pricing for pea-derived ingredients.
Controlled use of endo- and exo-proteases gives manufacturers greater latitude to design hydrolysates around a specified functional outcome rather than accepting a broad, inconsistent cleavage profile. That capability is valuable in applications where solubility, peptide size, and nutritional positioning must be balanced against formulation stability and taste.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
The production economics of hydrolysates remain materially more demanding than those of conventional concentrates and isolates. Enzyme procurement, process control, inactivation, separation, and drying requirements make scale, process efficiency, and customer mix central to profitability. As a result, the market is better positioned in applications where functionality has a direct commercial value than in commodity formulations where ingredient substitution is straightforward.
Allergen declaration obligations shape the addressable market as much as they shape labeling. Soy and wheat remain commercially important inputs, but their use can be constrained in allergy-sensitive, institutional, and infant-adjacent products. That creates a durable reformulation opportunity for pea and rice formats, while also increasing the cost of maintaining broad source portfolios.
Bitterness is a technical-commercial barrier rather than a minor sensory inconvenience. Higher degrees of hydrolysis can improve functionality while creating flavor challenges that require post-treatment, encapsulation, or flavor masking. Suppliers that can manage this trade-off without compromising clean-label positioning will be better placed to expand beyond specialty applications.
GMI Analyst View
We view the forecast as being governed by the gap between hydrolysates' functional value and their cost-to-formulate. Performance, clinical, and specialized nutrition channels can justify the added processing and qualification burden, whereas mainstream food applications will remain selective until producers improve sensory outcomes and processing efficiency. The most durable growth should accrue where buyers treat hydrolysates as a performance-enabling specification rather than a commodity protein substitute.
Plant Protein Hydrolysate Market Segment Analysis
By Source
Soy
The soy segment generated USD 909 million in 2025 and is expected to account for 33.4% of the plant protein hydrolysate market by 2035. Soy retains a broad commercial base because of established raw-material availability, mature ingredient-processing infrastructure, and familiarity among formulators in food, nutrition, and feed applications. Its long-term position will depend on sustaining performance and cost advantages as allergen-sensitive formulations increasingly diversify toward alternative plant sources.
Wheat
Wheat is projected to generate USD 795 million by 2035, following a 23.7% market share in 2025. Its commercial relevance is strongest in savory systems and other formulations where hydrolysis can improve solubility and flavor contribution. The segment faces a balancing act between its established functional role and the preference for gluten-free or allergen-conscious specifications in selected consumer-facing categories.
Pea
Pea is expected to reach USD 950 million by 2035 and expand at a 7.8% CAGR (2026-2035). Its momentum reflects the alignment of allergen-conscious formulation, non-GMO positioning, and expanding upstream processing capacity. Pea hydrolysates are particularly well positioned where formulators require a plant-derived ingredient that can support premium nutritional claims without the commercial constraints associated with soy or wheat declarations.
Rice
Rice generated USD 243 million in 2025 and is projected to represent 10.6% of the market by 2035. The source carries particular strategic value in hypoallergenic and specialty nutrition systems, where its sensory profile and regulatory acceptance support a higher specification threshold. Its opportunity is less dependent on broad commodity substitution than on maintaining consistency, traceability, and validated functional performance.
Hemp
Hemp is projected to generate USD 222 million by 2035 and expand at an 8.3% CAGR (2026-2035). Growth is emerging from premium nutrition and nutraceutical demand, where buyers place value on differentiated source credentials and protein quality. Broader commercialization will depend on continued regulatory clarity, scalable processing, and the ability of suppliers to convert consumer interest into repeatable formulation demand.
Sunflower
Sunflower accounted for 3.1% of the market in 2025 and is expected to generate USD 137 million by 2035. Its pale color profile and regional sourcing potential offer formulation advantages in applications where visual appearance and supply-chain proximity matter. However, processing complexity and the need to manage color stability constrain its pace of scale-up relative to larger alternative sources.
By Form
Powder
Powder generated USD 1.72 billion in 2025 and is expected to account for 65.4% of the market by 2035. It remains the principal commercial format because it integrates efficiently into dry blending, supports ambient logistics, and fits established manufacturing workflows for nutritional powders, bars, and fortified foods. The format's leadership is therefore likely to persist even as liquid alternatives gain ground in applications where direct incorporation reduces processing steps.
Liquid
Liquid is projected to reach USD 1.36 billion by 2035 and expand at a 7.0% CAGR (2026-2035). The format addresses a clear operational need in ready-to-drink beverages and clinical preparations by removing reconstitution from the production process. Its adoption is most compelling where manufacturers value consistent dispersion, process efficiency, and direct integration into liquid product lines.
Spray-Dried Powder
Spray-dried powder generated USD 1.46 billion in 2025 and is projected to represent 54.3% of the market by 2035. Its position reflects the throughput, familiarity, and scalable process control associated with spray drying. The format will remain an industrial workhorse, although growth in specialty drying methods and liquids will gradually diversify the overall format mix.
Freeze-Dried Powder
Freeze-dried powder generated USD 259 million in 2025 and is expected to expand at a 5.4% CAGR (2026-2035). It is suited to applications where preservation of heat-sensitive functionality and cold-water solubility warrant a higher processing burden. This narrows its role to clinical, pharmaceutical-grade, and premium recovery formulations, but also gives it defensible relevance where product performance outweighs cost considerations.
Aqueous Solution
Aqueous solution accounted for 18.6% of market revenue in 2025 and is projected to generate USD 843 million by 2035. The sub-format is important to beverage manufacturers that require stable viscosity, controlled concentration, and dependable batch-to-batch behavior. Supplier differentiation in this category rests on process standardization and quality assurance rather than merely supplying a liquid protein input.
Paste/Concentrated
Paste and concentrated formats are projected to account for 13.1% of the market by 2035 and expand at a 7.9% CAGR (2026-2035). Their value proposition lies in reducing transport volume while enabling controlled dosing in high-throughput food manufacturing. The format is especially relevant to savory systems and prepared foods where concentration, solubility, and flavor contribution must be managed simultaneously.
By Application
Food & Beverages
Food & beverages accounted for 34.6% of market revenue in 2025 and are expected to generate USD 1.23 billion by 2035. This remains the largest application because hydrolysates can support flavor development, emulsification, and protein fortification across diverse food matrices. Penetration will nevertheless remain uneven, as lower-cost concentrates and isolates can satisfy some functional needs in price-sensitive formulations.
Infant Formula
Infant formula generated USD 286 million in 2025 and is expected to represent 10.2% of the market by 2035. This is a highly controlled segment in which qualification, traceability, and consistent peptide profiles shape supplier access. European guidance recognizes soy protein isolate and hydrolyzed rice protein isolate for infant-formula applications, while U.S. guidance identifies soy as the applicable plant-based component for healthy full-term infants [6]Frontiers in Nutrition / ILSI Europe. "Plant-Based Proteins for Infant Formula: Findings and Recommendations from the ILSI Europe Workshop." frontiersin.org. Those boundaries give approved hydrolysate formats a defensible position while limiting rapid source diversification.
Sports & Performance Nutrition
Sports & performance nutrition is projected to generate USD 685 million by 2035 and expand at a 6.4% CAGR (2026-2035). The application rewards functionality that is visible to brands and consumers, including solubility, digestibility positioning, and formulation flexibility. It is therefore a core outlet for suppliers able to pair technical performance with sensory consistency and credible specification support.
Clinical & Medical Nutrition
Clinical & medical nutrition is projected to generate USD 240 million by 2035 and expand at a 6.9% CAGR (2026-2035). Demand is underpinned by products designed for patients with compromised digestion, recovery needs, or specialized nutritional requirements. Qualification barriers are high, but successful suppliers benefit from greater switching costs and a customer base that values reliable clinical and manufacturing performance.
Animal Feed
Animal feed generated USD 532 million in 2025 and is projected to generate USD 860 million by 2035. The application supplies an important volume base for hydrolysate producers, particularly where digestibility and feed-performance considerations support the use of processed plant proteins. Its economics differ from specialized nutrition, making efficient manufacturing and raw-material access especially important.
Pharmaceuticals & Nutraceuticals
Pharmaceuticals & nutraceuticals are expected to account for 11.6% of market revenue by 2035, compared with USD 223 million in 2025. This application favors producers able to deliver consistent peptide profiles, low microbial loads, and rigorous traceability. The resulting premium environment makes the segment commercially attractive despite its higher qualification and documentation requirements.
GMI Analyst View
We see segmentation increasingly separating value-led demand from volume-led demand. Mature sources and powdered formats will remain central to market scale, but incremental opportunity is moving toward formats and sources that solve a specific customer problem: allergen positioning, liquid-process efficiency, clinical tolerability, or premium performance. The supplier advantage will come from application fit and formulation support, not from protein supply alone.
Plant Protein Hydrolysate Market Regional Analysis
North America Plant Protein Hydrolysate Market Analysis
North America generated USD 840 million in plant protein hydrolysate market revenue in 2025 and is projected to reach USD 1.22 billion by 2035. The region combines an established performance-nutrition consumer base with sophisticated food manufacturing and a broad ingredient distribution network. Its maturity favors suppliers that can support reformulation, scale, and quality assurance across multiple end uses rather than suppliers competing only on raw-material price.
U.S.
The U.S. generated USD 736 million in 2025 and is expected to represent 89.0% of North American demand by 2035. The country's scale reflects deep sports-nutrition, functional-food, and ingredient-processing ecosystems, along with relatively clear routes to market for established hydrolysate specifications. Domestic processing capacity and product-development capabilities make the U.S. the region's principal center for both demand creation and ingredient commercialization.
Canada
Canada accounted for 12.4% of North American revenue in 2025 and is expected to expand at a 2.6% CAGR (2026-2035). Its importance to the market exceeds domestic consumption because of its role in pea and pulse supply chains. The opportunity is to convert that agricultural position into higher-value processing and downstream hydrolysate manufacturing as local infrastructure develops.
Europe Plant Protein Hydrolysate Market Analysis
Europe accounted for 28.8% of the plant protein hydrolysate market in 2025 and is projected to generate USD 1.07 billion by 2035. The region's diverse food, clinical-nutrition, and specialty-ingredient base provides multiple demand channels, while high regulatory and documentation standards favor suppliers with established technical capabilities. Clean-label sourcing and traceability expectations reinforce the commercial value of locally supported plant-protein platforms.
Germany
Germany generated USD 175 million in 2025 and is expected to generate USD 283 million by 2035. Its food-manufacturing depth, technical-service infrastructure, and plant-based innovation activity make it an important regional market for both hydrolysate use and product development. The country's role in European supply chains also supports its value as a distribution and applications-development center.
UK
The UK is projected to generate USD 216 million by 2035, after accounting for 19.9% of European demand in 2025. Retailer-led sustainability requirements and a well-developed plant-based innovation ecosystem support interest in pea and rice alternatives. Regulatory divergence remains a commercial consideration for newer sources, but established hydrolysate formats retain a clearer path to customer adoption.
France
France generated USD 125 million in 2025 and is expected to expand at a 4.2% CAGR (2026-2035). The market benefits from strong savory-food, dairy-alternative, and specialized-nutrition activity, alongside proximity to important European ingredient-development capabilities. Collaborative product development between suppliers and food manufacturers supports the adoption of differentiated hydrolysate applications.
Asia Pacific Plant Protein Hydrolysate Market Analysis
Asia Pacific is projected to generate USD 1.23 billion by 2035 and expand at a 6.8% CAGR (2026-2035). The plant protein hydrolysate market in the region is supported by expanding functional-nutrition consumption, a growing food-manufacturing base, and rising interest in localized plant-protein solutions. Demand mechanisms vary widely across markets, making localized formulation, distribution, and regulatory capability essential to capture the region's opportunity.
China
China is projected to generate USD 509 million by 2035 and expand at a 7.4% CAGR (2026-2035). Domestic soybean processing, fitness-oriented consumer demand, and export-focused food manufacturing create a broad platform for hydrolysate development. The pace of adoption will be influenced by ingredient-labeling practices, claims frameworks, and manufacturers' ability to tailor products to local food and beverage preferences.
Japan
Japan generated USD 122 million in 2025 and is projected to represent 16.6% of Asia Pacific demand by 2035. Its functional-food culture and demand for easy-to-digest nutritional products support the use of bioactive and specialized hydrolysates. An aging population further reinforces demand for nutrition systems where digestibility and precise formulation are commercially relevant.
South Korea
South Korea accounted for 12.1% of Asia Pacific revenue in 2025 and is projected to generate USD 137 million by 2035. Developed processed-food and sports-nutrition channels provide a receptive base for high-specification ingredients. Premium retail access and domestic food-company participation in plant-protein reformulation strengthen the market's prospects.
India
India is projected to generate USD 201 million by 2035 and expand at an 8.4% CAGR (2026-2035). Urbanization, a large vegetarian consumer base, rising health awareness, and expanding sports-nutrition retail create a favorable demand setting. The central constraint is processing capacity; as domestic ingredient manufacturing expands, import substitution could materially improve the market's accessibility.
Latin America Plant Protein Hydrolysate Market Analysis
Latin America generated USD 145 million in 2025 and is projected to reach USD 239 million by 2035. Agricultural integration, particularly in soy-producing economies, provides an input-cost advantage, while urban demand for functional foods and sports nutrition broadens the customer base. The region's growth will depend on continued improvements in ingredient-processing capability, quality systems, and route-to-market infrastructure.
Brazil
Brazil generated USD 72 million in 2025 and is expected to represent 52.3% of Latin American demand by 2035. Its soybean value chain provides a structural raw-material advantage for hydrolysate production, while domestic interest in protein-enriched food and performance nutrition supports local demand. The market can serve both domestic customers and export-oriented manufacturing strategies.
Mexico
Mexico is projected to generate USD 68 million by 2035, following a 29.7% regional share in 2025. Its large food and beverage manufacturing sector supports demand for hydrolysates in savory and formulation-intensive uses, while sports-nutrition channels are creating a market for higher-specification formats. Cross-border supply-chain conditions remain important to the pace and economics of market development.
Middle East & Africa Plant Protein Hydrolysate Market Analysis
Middle East & Africa is expected to account for 4.1% of market revenue by 2035 and expand at a 5.3% CAGR (2026-2035). The region remains early stage and substantially import dependent, with demand concentrated in premium food manufacturing, clinical procurement, and urban wellness categories. Growth depends on distribution reliability, regulatory clarity, and the ability of suppliers to position hydrolysates within high-value rather than mass-market use cases.
Saudi Arabia
Saudi Arabia generated USD 29 million in 2025 and is expected to expand at a 6.0% CAGR (2026-2035). Investment in domestic food manufacturing and a growing health-and-wellness consumer base support demand for functional ingredients. The opportunity is concentrated in supplements, premium food products, and locally developed nutrition platforms.
UAE
The UAE is projected to generate USD 42 million by 2035, after accounting for 25.0% of regional demand in 2025. Its position as a food-trading and manufacturing hub supports both direct consumption and distribution across neighboring markets. Premium retail and an internationally aligned food-safety environment make it a practical entry point for established hydrolysate suppliers.
South Africa
South Africa accounted for 19.8% of regional revenue in 2025 and is projected to generate USD 29 million by 2035. Its comparatively developed food-manufacturing base supports hydrolysate use in fortified foods and sports nutrition. Price sensitivity, logistics, and imported-input costs will continue to limit the breadth of mass-market adoption.
GMI Analyst View
We expect regional competition to be shaped less by headline economic size than by the interaction of processing capability, regulatory familiarity, and application-specific demand. North America retains an incumbent advantage in commercialization, while Asia Pacific offers the clearest expansion runway for suppliers that can localize products and customer support. Europe remains strategically important because its regulatory discipline and formulation sophistication reward credible, technically differentiated offerings.
Plant Protein Hydrolysate Market Share & Competitive Landscape
The plant protein hydrolysate market share landscape is moderately fragmented: ADM, Kerry Group, Roquette, DuPont/IFF, and Cargill collectively accounted for approximately 26.9% of global revenue in 2025. This leaves meaningful room for regional processors and specialist manufacturers, but scale remains valuable where customers require dependable source access, technical support, and consistent hydrolysis performance across multiple plants and applications.
ADM held a 14.1% market share in 2025, supported by vertical integration across agricultural origination, protein processing, and food-ingredient supply. Its strategic advantage lies in the ability to connect scale economics with established customer relationships. ADM's streamlining of its soy protein production network around the recommissioned Decatur East facility illustrates the industry's emphasis on throughput efficiency and network optimization [7]ADM. "ADM Announces Streamlining of Soy Protein Production Network." adm.com.
Kerry Group held a 4.6% market share in 2025. Its competitive position rests more heavily on applications expertise and co-development capability than on commodity scale alone, which is important in categories where customers need help resolving sensory, stability, or process challenges. This type of technical collaboration can create durable relationships in clinical, nutrition, and food-manufacturing accounts.
Roquette accounted for 3.3% market share in 2025 and is positioned around plant-protein platform development, particularly in pea-based systems. The company's expansion of its NUTRALYS portfolio into textured wheat and pea proteins signals a strategy of extending plant-protein relevance across adjacent finished-food applications, strengthening the commercial ecosystem around its specialty ingredient business [3]Roquette. "Roquette Grows NUTRALYS® Plant Protein Portfolio." roquette.com.
Cargill's agricultural supply-chain reach supports a competitive input-cost position in hydrolyzed wheat and broader plant-based ingredient systems. Tereos, Avebe, and Emsland Group are differentiated by their European processing footprints and proximity to food manufacturers seeking regional sourcing, while Axiom Foods, Fuji Oil Holdings, Sotexpro, Armor Proteines, Shandong Sinoglory Health Food, New Alliance Fine Chem, Yantai Oriental Protein Tech, and Water Solu compete through source specialization, targeted functionality, regional access, or customized hydrolysis capability.
Recent Industry Developments
ADM announced in August 2025 that it would streamline its soy protein production network around the recommissioned Decatur East facility in Illinois while ceasing operations at its Bushnell facility. The action indicates a focus on operating efficiency and capacity utilization within a core supply platform for soy-based ingredients [7]ADM. "ADM Announces Streamlining of Soy Protein Production Network." adm.com.
Roquette expanded its NUTRALYS plant-protein portfolio in June 2025 with new textured wheat and pea protein offerings aimed at finished-food applications. The development broadens the company's platform across plant-protein formats and creates adjacent commercial opportunities for specialized ingredient solutions [3]Roquette. "Roquette Grows NUTRALYS® Plant Protein Portfolio." roquette.com.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →